Description
A dual inhibitor of the two mammalian forms of PLD, PLD1 and PLD2 (IC50s = 6 and 20 nM, respectively); penetrates the CNS and is functional in vivo when given intraperitoneally; has potential applications in oncology and virology
Formal name: 4-bromo-N-[(1S)-2-[1-(3-fluorophenyl)-4-oxo-1,3,8-triazaspiro[4.5]dec-8-yl]-1-methylethyl]-benzamide
Synonyms: CID 56593087
Molecular weight: 489.4
CAS: 1426916-00-8
Purity: ≥95%
Formulation: A crystalline solid
Product Type|Biochemicals|Small Molecule Inhibitors|Phospholipases||Research Area|Cancer|Cell Migration & Metastasis||Research Area|Lipid Biochemistry|Glycerophospholipids|Phospholipases